Antibiotic resistance in the absence of selective pressure

被引:68
作者
Gillespie, SH [1 ]
机构
[1] UCL Royal Free & Univ Coll, Sch Med, London NW3 2PF, England
关键词
antibiotic resistance; selective pressure; evolution; multiple drug resistant tuberculosis;
D O I
10.1016/S0924-8579(00)00340-X
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antibiotic resistance poses a serious threat to modern medical practice making treatment more difficult and is associated with increased mortality among patients infected with resistant organisms. There is clear evidence that acquisition of resistance is associated with a decrease in the fitness of the organisms at least in the short term. Evidence from in vitro experiments indicates that bacteria have the ability to adapt to this deficit and recover fitness on serial passage. More recent results show that identical organisms isolated from patients in outbreaks have an initial deficit but that adaptation occurs in vivo. Strategies directed towards controlling resistance must move beyond wishful thinking that supposes that these organisms will disappear merely with control of prescribing. In some cases, resistance will not disappear because there is no evolutionary disadvantage in being resistant once adaptation has taken place. It is important. therefore. that we direct out efforts towards preventing primary resistance emerging and in limiting the spread of resistant strains. Ultimately, we must look again to new drug discovery to improve our therapeutic armoury. (C) 2001 Elsevier Science B.V. and International Society of Chemotherapy All rights reserved.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 50 条
  • [1] CHARACTERIZATION OF FLUOROQUINOLONE-RESISTANT MUTANT STRAINS OF MYCOBACTERIUM-TUBERCULOSIS SELECTED IN THE LABORATORY AND ISOLATED FROM PATIENTS
    ALANGADEN, GJ
    MANAVATHU, EK
    VAKULENKO, SB
    ZVONOK, NM
    LERNER, SA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) : 1700 - 1703
  • [2] BANERJEE A, 1994, SCIENCE, V253, P230
  • [3] TRANSMISSION OF MULTIDRUG-RESISTANT SEROTYPE 23F STREPTOCOCCUS-PNEUMONIAE IN GROUP DAY-CARE - EVIDENCE SUGGESTING CAPSULAR TRANSFORMATION OF THE RESISTANT STRAIN IN-VIVO
    BARNES, DM
    WHITTLER, S
    GILLIGAN, PH
    SOARES, S
    TOMASZ, A
    HENDERSON, FW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 890 - 896
  • [4] BARNETT M, 1953, BRIT J EXP PATHOL, V34, P568
  • [5] Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology
    Bifani, PJ
    Mathema, B
    Liu, ZY
    Moghazeh, SL
    Shopsin, B
    Tempalski, B
    Driscoll, J
    Frothingham, R
    Musser, JM
    Alcabes, P
    Kreiswirth, BN
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2321 - 2327
  • [6] Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis
    Billington, OJ
    McHugh, TD
    Gillespie, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 1866 - 1869
  • [7] Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium
    Björkman, J
    Samuelsson, P
    Andersson, DI
    Hughes, D
    [J]. MOLECULAR MICROBIOLOGY, 1999, 31 (01) : 53 - 58
  • [8] Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance
    Björkman, J
    Nagaev, I
    Berg, OG
    Hughes, D
    Andersson, DI
    [J]. SCIENCE, 2000, 287 (5457) : 1479 - 1482
  • [9] TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER
    BLOOM, BR
    MURRAY, CJL
    [J]. SCIENCE, 1992, 257 (5073) : 1055 - 1064
  • [10] EVOLUTION OF A BACTERIA PLASMID ASSOCIATION
    BOUMA, JE
    LENSKI, RE
    [J]. NATURE, 1988, 335 (6188) : 351 - 352